v3.26.1
Note 9 - Shareholders' Equity (Details Textual)
€ / shares in Units, € in Thousands
1 Months Ended 12 Months Ended
Dec. 23, 2024
€ / shares
Nov. 21, 2021
shares
Dec. 31, 2020
€ / shares
shares
Dec. 31, 2025
EUR (€)
€ / shares
shares
Dec. 31, 2024
EUR (€)
€ / shares
shares
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Sep. 05, 2025
€ / shares
Aug. 13, 2025
€ / shares
shares
Aug. 12, 2025
€ / shares
shares
Dec. 22, 2024
€ / shares
Preferred Stock, Shares Authorized       1,401 1,401       1,401 0  
Preferred Stock, Par or Stated Value Per Share | € / shares       € 300 € 300     € 300 € 300    
Preferred Stock, Shares Issued       1,401 0            
Preferred Stock, Shares Outstanding       1,401 0            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | €       € 1,850 € 1,938            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value | €       (1,850) € (1,938)            
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value | €       1,862              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value | €       € 1,862              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term       5 years 9 months 29 days 10 months 24 days 2 years          
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Year)       5 years 9 months 29 days              
Restricted Stock Units (RSUs) [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted   854                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period         0 266 213        
CSOP [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures     41,157                
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | € / shares     € 50                
CSOP [Member] | Share-Based Payment Arrangement, Option [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period     1 year                
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period     4 years                
Reverse Stock Split [Member]                      
Stockholders' Equity Note, Stock Split, Conversion Ratio 75                    
Ordinary Shares [Member]                      
Common Stock, Shares Authorized       120,000,000 120,000,000       120,000,000 4,300,000  
Common Stock, Par or Stated Value Per Share | € / shares € 0.02     € 0.01 € 0.01       € 0.01 € 0.02 € 0.06
Common Stock, Shares, Issued       1,424,834 1,409,885            
Common Stock, Shares, Outstanding       1,424,834 1,409,885            
Ordinary Shares [Member] | Reverse Stock Split [Member]                      
Stockholders' Equity Note, Stock Split, Conversion Ratio 75                    
High Voting Shares [Member]                      
Common Stock, Shares Authorized       40,000 40,000       40,000 53,400  
Common Stock, Par or Stated Value Per Share | € / shares € 0.5     € 0.25 € 0.25       € 0.25 € 0.5 € 1.5
Common Stock, Shares, Issued       40,000 40,000            
Common Stock, Shares, Outstanding       40,000 40,000            
High Voting Shares [Member] | Reverse Stock Split [Member]                      
Stockholders' Equity Note, Stock Split, Conversion Ratio 75